Psychiatr. praxi. 2011;12(2):56-60

Emotional and behavioral disturbances in dementia

doc.MUDr.Roman Jirák, CSc.
Psychiatrická klinika Praha

Behavioral and emotional disturbances are one of the three basic circles of the functional disturbances in dementias. Their occurence

mostly increases with the intensity of dementias. In the article there are described single types of the behavioral disturbances including

of the associate confussions and thein basic therapy. Emotional disturbances in dementias are also very frequent – partly increased of

unappropriate affects, partly occurence of pathic moods, first of all the depression and anxiety. There are described basal procedures of

the therapy of associated depression and anxiety in dementias.

Keywords: antidepressants, antipsychotics, anxiety, behavioral disturbances, dementia, depression

Published: May 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirák R. Emotional and behavioral disturbances in dementia. Psychiatr. praxi. 2011;12(2):56-60.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Birren JE, Bruce Sloane R, Cohen GD (eds.), et al. Handbook of mental health and aging. Second edition. Academic Press, inc., USA, 1992.
    2. Martin JH, Haynes LC. Depression, delirium and dementia in the elderly patiens. AORN J. 2000; 72(2): 209-217. Go to original source... Go to PubMed...
    3. NICE guideline: CG42 Dementia; http://guidance.nice.org.uk/cg42/niceguidance/pdf/English (22. 4. 2009).
    4. Qizilbash N, Schneider LS, Chui H, et al. Evidence-based Dementia practice. Oxford: Blackwell Science Ltd a Blackwell publishing company, 2003: 428-446.
    5. Sultzer DL, Davis SM, Tariot PN, et al. Clinical symptom responses to atypical antipsychotic medication in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008; 165: 844-854. Go to original source... Go to PubMed...
    6. Caltagirone C, Bianchetti A, Di Luca M, et al. Guidelines for the treatment of Alzheimer´s disease from the Italian Association of Psychogeriatrics. Drugs & Aging 2005; 22(suppl. 1): 1-26. Go to original source... Go to PubMed...
    7. Cummings LJ, McRae T, Zhang R. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriat Psychiatry 2006; 14: 605-612. Go to original source... Go to PubMed...
    8. Gauthier S, Wirth Y, Möbius HJ. Effects of memantine on behavioral symptoms in Alzheimer´s disease patients: an analkysis of the Neuropsychiatric Inventory (NPI) data of two randomized, controlled studies. Int J Geriatr Psychiatry 2005; 20(5): 459-464. Go to original source... Go to PubMed...
    9. Jirák R, Borzová C, Konrád J, et al. Demence. In: Raboch J, Anders M, Praško J, (eds.), a kol. Psychiatrie. Doporučené postupy psychiatrické péče 2. Infopharm, Praha, 2006: 22-37.
    10. Jirák R, Franková V. Demence a jiné organicky podmíněné poruchy. In: Seifertová D, Praško J, Horáček J, Höschl C. (eds), a kol. Postupy v léčbě psychických poruch. Algoritmy České neuropsychofarmakologické společnosti. Medical Tribune CZ, Praha, 2008: 12-29.
    11. Jirák R, Franková V. Demence. In: Psychiatrie, doporučené postupy psychiatrické péče III, ed. Raboch J, Anders M, Hellerová P, Uhlíková P. Psychiatrická společnost ČSL JEP, Česká psychiatrická společnost o. s., 2010: 20-53.
    12. Wengel SP, Roccaforte WH, Burke WJ. Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 1998; 11: 159-161. Go to original source... Go to PubMed...
    13. Allain H, Dautzenberg PHJ, Maurer K, et al. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 2000; 148: 361-366. Go to original source... Go to PubMed...
    14. Alexopoulos GS, Streim J, Carpenter D. Using antipsychotic agents in older patients. J Clin Psychiatry 2004; 65(Suppl. 2): 5-99.
    15. Lonergan E, Luxenberg J, Colford JM, Birks J. Haloperidol for agitation in dementia. Cochrane Database of Systemnatic Reviews 2002, Issue 2. Last assessed as up-to-date: Sept. 12. 2008. Go to original source...
    16. Brodaty H, Ames D, Snowdon J, et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003; 64(2): 134-143. Go to original source... Go to PubMed...
    17. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer´s disease. N Engl J Med., 2006; 12, 355(15): 1525-1538. Go to original source... Go to PubMed...
    18. Wooltorton E. Risperidone (Risperdal): Increased rate of cerebrovascular events in dementia trials. CMAJ 2004; 167(11): 1269-1270. Go to original source... Go to PubMed...
    19. Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer disease in nursing care facilities. Archives of General Psychiatry 2000; 57: 968-976. Go to original source... Go to PubMed...
    20. Wooltotron E. Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials. CMAJ 2004; 27, 170(9).doi: 10.1503/cmaj.1040539. Go to original source... Go to PubMed...
    21. Paleacu D, Barak Y, Mirecky I, Mazeh D. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer´s disease patients: a 6-week, double-blind, placebo-controlled study. Int Geriatr Psychiatry 2008; 23(4): 393-400. Go to original source... Go to PubMed...
    22. Zhong KX, Tariot PN, Mintzer J, et al. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebocontrolled study. Curr Alzheimer Res. 2007; 4(1): 81-93. Go to original source... Go to PubMed...
    23. Rochon PA, Normand SL, Gomes T. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008; 168(10): 1090-1096. Go to original source... Go to PubMed...
    24. Baldwin RC, Chiu E, Katona C, Graham N. Guidelines on Depression in Older People. Martin Dunitz, London, UK, 2002: 162. Go to original source...
    25. Anderson I, Ferrier I, Baldwin R, et al. Evicence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22(4): 343-396. Go to original source... Go to PubMed...
    26. Mintzer JE, Brawman-Mintzer O, Mirski DF, Barkin K. Anxiety in the Behavioral and Psychological Symptoms of Dementia. International Psychogeriatrics 2000; 12: 139-142. Go to original source...
    27. Raboch J, Jirák R, Paclt I. Psychofarmakologie pro praxi. Triton, Praha, 2007: 167.
    28. Seignourel PJ, Kunik, ME, Snow L, et al. Anxiety in dementia: A critical review. Clinical Psychology Review 2008; 28(7): 1071-1082. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.